OOIR: Observatory of International Research

Papers

(The H4-Index of BJU International is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Sexual function in adolescence after childhood hypospadias repair: a patient‐reported outcome study	91
Reply to ‘Comment on Bertini et al.: area deprivation and PSA screening disparities’ and ‘Comment on socioeconomic disparities in prostate cancer screening: the impact of the Area Deprivati	80
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	64
Impact of the COVID‐19 pandemic on the burnout rates of graduating Canadian Urology residents	58
Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit	51
Building a research profile during residency	51
Response to Chen et al.	51
The European Association of Urology talent incubator: bridging competencies for holistic urological care	46
Surveillance of non‐muscle ‐invasive bladder cancer with blue‐light cystoscopy: a meta‐analysis	45
April's reviewers of the month	45
Acupuncture: a promising adjuvant strategy for pain management among the patients with prostate cancer	44
	42
April's reviewers of the month	42
Prolonged ischaemia during partial nephrectomy: impact of warm vs cold	40
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomised controlled trial	40
Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?	39
Nephrectomy for kidney tumour increases the risk of de novo arterial hypertension	37
Comparison of the effects of extrinsic compression on the drainage performance of three ureteric stents	36
Recent key papers in prostate cancer	35
Vitamin C as an adjunct to methenamine hippurate use after ALTAR: ego or evidence‐based?	33
The LANDMARK project: providing summaries of key papers that have shaped urological practice	32
Real‐world performance of Uromonitor® in urothelial bladder cancer detection: a multicentric trial	31
Active surveillance versus enzalutamide for low‐risk prostate cancer – was it really a trial we needed?	31
Editorial Board	31
Flexible ureterorenoscopy or extracorporeal shockwave lithotripsy in stone disease and bevacizumab for hereditary and sporadic papillary renal‐cell cancer	29

	29
Author Index	29
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’	28